Faculty of Medicine
Not Assigned to Any Medical Research Department
Publications
14 found
Show per page
Brandt, Anna et al. (2024) ‘Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial’, Frontiers in Oncology, 14. Available at: https://doi.org/10.3389/fonc.2024.1283266.
Brandt, Anna et al. (2024) ‘Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial’, Frontiers in Oncology, 14. Available at: https://doi.org/10.3389/fonc.2024.1283266.
Brandt, Anna et al. (2023) ‘Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma’, Cancers, 15. Available at: https://doi.org/10.3390/cancers15072051.
Brandt, Anna et al. (2023) ‘Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma’, Cancers, 15. Available at: https://doi.org/10.3390/cancers15072051.
Brandt, A. et al. (2019) ‘A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells’, Leukemia and Lymphoma, 60(2), pp. 334–340. Available at: https://doi.org/10.1080/10428194.2018.1482538.
Brandt, A. et al. (2019) ‘A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells’, Leukemia and Lymphoma, 60(2), pp. 334–340. Available at: https://doi.org/10.1080/10428194.2018.1482538.
Oberle, A. et al. (2017) ‘Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection’, Haematologica, 102(9), pp. 368–370. Available at: https://doi.org/10.3324/haematol.2017.169235.
Oberle, A. et al. (2017) ‘Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection’, Haematologica, 102(9), pp. 368–370. Available at: https://doi.org/10.3324/haematol.2017.169235.
Akyüz, N. et al. (2017) ‘T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker’, International Journal of Cancer, 140(11), pp. 2535–2544. Available at: https://doi.org/10.1002/ijc.30549.
Akyüz, N. et al. (2017) ‘T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker’, International Journal of Cancer, 140(11), pp. 2535–2544. Available at: https://doi.org/10.1002/ijc.30549.
Braig, F. et al. (2017) ‘Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking’, Blood, 129(1), pp. 100–104. Available at: https://doi.org/10.1182/blood-2016-05-718395.
Braig, F. et al. (2017) ‘Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking’, Blood, 129(1), pp. 100–104. Available at: https://doi.org/10.1182/blood-2016-05-718395.
Oberle, A. et al. (2017) ‘Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA’, Haematologica, 102(6), pp. 1105–1111. Available at: https://doi.org/10.3324/haematol.2016.161414.
Oberle, A. et al. (2017) ‘Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA’, Haematologica, 102(6), pp. 1105–1111. Available at: https://doi.org/10.3324/haematol.2016.161414.
Rossi, A. et al. (2017) ‘Mutational landscape reflects the biological continuum of plasma cell dyscrasias’, Blood Cancer Journal, 7(2). Available at: https://doi.org/10.1038/bcj.2017.19.
Rossi, A. et al. (2017) ‘Mutational landscape reflects the biological continuum of plasma cell dyscrasias’, Blood Cancer Journal, 7(2). Available at: https://doi.org/10.1038/bcj.2017.19.
Brandt, Anna and Binder, Mascha (2015) ‘The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies: Author’s reply’, Leukemia and Lymphoma, 56(12). Available at: https://doi.org/10.3109/10428194.2015.1050667.
Brandt, Anna and Binder, Mascha (2015) ‘The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies: Author’s reply’, Leukemia and Lymphoma, 56(12). Available at: https://doi.org/10.3109/10428194.2015.1050667.
Rissiek, Anne et al. (2014) ‘Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia’, International Journal of Cancer, 135(10), pp. 2370–2379. Available at: https://doi.org/10.1002/ijc.28884.
Rissiek, Anne et al. (2014) ‘Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia’, International Journal of Cancer, 135(10), pp. 2370–2379. Available at: https://doi.org/10.1002/ijc.28884.
Flammiger, Anna et al. (2012) ‘Critical imbalance of TNF-α and soluble TNF receptor 1 in a patient with macrophage activation syndrome: Potential implications for diagnostics and treatment’, Acta Haematologica, 128(2), pp. 69–72. Available at: https://doi.org/10.1159/000338179.
Flammiger, Anna et al. (2012) ‘Critical imbalance of TNF-α and soluble TNF receptor 1 in a patient with macrophage activation syndrome: Potential implications for diagnostics and treatment’, Acta Haematologica, 128(2), pp. 69–72. Available at: https://doi.org/10.1159/000338179.
Flammiger, Anna et al. (2009) ‘SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells’, Journal of Investigative Dermatology, 129(4), pp. 945–953. Available at: https://doi.org/10.1038/jid.2008.316.
Flammiger, Anna et al. (2009) ‘SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells’, Journal of Investigative Dermatology, 129(4), pp. 945–953. Available at: https://doi.org/10.1038/jid.2008.316.
Flammiger, Anna and Maibach, Howard (2006) ‘Sulfuric acid burns (corrosion and acute irritation): Evidence-based overview to management’, Cutaneous and Ocular Toxicology, 25(1), pp. 55–61. Available at: https://doi.org/10.1080/15569520500536634.
Flammiger, Anna and Maibach, Howard (2006) ‘Sulfuric acid burns (corrosion and acute irritation): Evidence-based overview to management’, Cutaneous and Ocular Toxicology, 25(1), pp. 55–61. Available at: https://doi.org/10.1080/15569520500536634.
Flammiger, Anna and Maibach, Howard (2006) ‘Drug dosage in the elderly: Dermatological drugs’, Drugs and Aging, 23(3), pp. 203–215. Available at: https://doi.org/10.2165/00002512-200623030-00003.
Flammiger, Anna and Maibach, Howard (2006) ‘Drug dosage in the elderly: Dermatological drugs’, Drugs and Aging, 23(3), pp. 203–215. Available at: https://doi.org/10.2165/00002512-200623030-00003.